UB Paderborn / Katalog / Suche / in CDI

Role of Osteocytes in Myeloma Bone Disease: Anti-sclerostin Antibody as New Therapeutic Strategy

Frontiers in immunology, 2018-10, Vol.9, p.2467-2467

2018

Volltextzugriff (PDF)

Mechanism of Action of Bortezomib and the New Proteasome Inhibitors on Myeloma Cells and the Bone Microenvironment: Impact on Myeloma-Induced Alterations of Bone Remodeling

BioMed research international, 2015-01, Vol.2015, p.172458-13

2015

Volltextzugriff (PDF)

The Proteasome Inhibitor Bortezomib Maintains Osteocyte Viability in Multiple Myeloma Patients by Reducing Both Apoptosis and Autophagy: A New Function for Proteasome Inhibitors

Journal of bone and mineral research, 2016-04, Vol.31 (4), p.815-827

2016

Volltextzugriff (PDF)

Assessing satisfaction in simulation among nursing students: psychometric properties of the Satisfaction with Simulation Experience - Italian Version scale

BMC nursing, 2024-04, Vol.23 (1), p.300-300, Article 300

2024

Volltextzugriff (PDF)

IL21R expressing CD14 + CD16 + monocytes expand in multiple myeloma patients leading to increased osteoclasts

Haematologica (Roma), 2017-04, Vol.102 (4), p.773

2017

Volltextzugriff (PDF)

Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients

Cancers, 2019-03, Vol.11 (3), p.321

2019

Volltextzugriff (PDF)

Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties

Oncotarget, 2017-05, Vol.8 (32), p.53053-53067

2017

Volltextzugriff (PDF)

New Insights into Osteogenic and Chondrogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells and Their Potential Clinical Applications for Bone Regeneration in Pediatric Orthopaedics

Stem Cells International, 2013-01, Vol.2013, p.312501-11

2013

Volltextzugriff (PDF)

NAD⁺-Metabolizing Ectoenzymes in Remodeling Tumor-Host Interactions: The Human Myeloma Model

Cells, 2015-09, Vol.4 (3), p.520-537

2015

Volltextzugriff (PDF)

The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells

Haematologica (Roma), 2016-03, Vol.101 (3), p.e107

2016

Volltextzugriff (PDF)

Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin?

International journal of hematology, 2017, Vol.105 (1), p.104-108

2017

Volltextzugriff (PDF)

The osteoblastic niche in the context of multiple myeloma

Annals of the New York Academy of Sciences, 2015-01, Vol.1335 (1), p.45-62

2015

Volltextzugriff (PDF)

Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion molecules

Experimental hematology, 2013-04, Vol.41 (4), p.387-397.e1

2013

Volltextzugriff (PDF)

Bone marrow monocyte-/macrophage-derived activin A mediates the osteoclastogenic effect of IL-3 in multiple myeloma

Leukemia, 2014-04, Vol.28 (4), p.951-954

2014

Volltextzugriff (PDF)

Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation

Oncotarget, 2017-08, Vol.8 (34), p.56598-56611

2017

Volltextzugriff (PDF)

Unraveling the contribution of ectoenzymes to myeloma life and survival in the bone marrow niche

Annals of the New York Academy of Sciences, 2015-01, Vol.1335 (1), p.10-22

2015

Volltextzugriff (PDF)

Randomised controlled prospective study of the use of adhesive elastic tape for the control of hand oedema in patients with a wrist fracture treated in a cast: a study protocol

International journal of orthopaedic and trauma nursing, 2022-02, Vol.44, p.100881, Article 100881

2022

Volltextzugriff (PDF)

The potential of inhibiting glutamine uptake as a therapeutic target for multiple myeloma

Expert opinion on therapeutic targets, 2017-03, Vol.21 (3), p.231-234

2017

Volltextzugriff (PDF)

Assessment and pain management during the triage phase of children with extremity trauma. A retrospective analysis in a Pediatric Emergency Room after the introduction of the PIPER recommendations

Acta bio-medica de l'Ateneo Parmense, 2020-11, Vol.91 (Suppl 12)

2020

Volltextzugriff (PDF)

Angiogenesis and Multiple Myeloma

Cancer microenvironment, 2011-12, Vol.4 (3), p.325-337

2011

Volltextzugriff (PDF)

The use of adhesive elastic tape for hand oedema control in patients with a wrist fracture treated in a cast: A pilot study

International journal of orthopaedic and trauma nursing, 2024-05, Vol.53, p.101059, Article 101059

2024

Volltextzugriff (PDF)

Relationship between Bone Marrow PD-1 and PD-L1 Expression and the Presence of Osteolytic Bone Disease in Multiple Myeloma Patients

Blood, 2018-11, Vol.132 (Supplement 1), p.3183-3183

2018

Volltextzugriff (PDF)

CD14+CD16+ Monocyte Binding to Myeloma Cells Is Required for Daratumumab Dependent Killing in Multiple Myeloma Patients

Blood, 2018-11, Vol.132 (Supplement 1), p.3200-3200

2018

Volltextzugriff (PDF)

Effect of Continuous Lenalidomide Treatment on Copy Number Alteration and Cytogenetic Abnormalities in Multiple Myeloma Cells

Blood, 2017-12, Vol.130, p.3039-3039

2017

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Role of Osteocytes in Myeloma Bone Disease: Anti-sclerostin Antibody as New Therapeutic Strategy

Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target

Mechanism of Action of Bortezomib and the New Proteasome Inhibitors on Myeloma Cells and the Bone Microenvironment: Impact on Myeloma-Induced Alterations of Bone Remodeling

The Proteasome Inhibitor Bortezomib Maintains Osteocyte Viability in Multiple Myeloma Patients by Reducing Both Apoptosis and Autophagy: A New Function for Proteasome Inhibitors

Assessing satisfaction in simulation among nursing students: psychometric properties of the Satisfaction with Simulation Experience - Italian Version scale

IL21R expressing CD14 + CD16 + monocytes expand in multiple myeloma patients leading to increased osteoclasts

Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients

Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties

New Insights into Osteogenic and Chondrogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells and Their Potential Clinical Applications for Bone Regeneration in Pediatric Orthopaedics

NAD⁺-Metabolizing Ectoenzymes in Remodeling Tumor-Host Interactions: The Human Myeloma Model

The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells

Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin?

The osteoblastic niche in the context of multiple myeloma

Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion molecules

Bone marrow monocyte-/macrophage-derived activin A mediates the osteoclastogenic effect of IL-3 in multiple myeloma

Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation

Unraveling the contribution of ectoenzymes to myeloma life and survival in the bone marrow niche

Randomised controlled prospective study of the use of adhesive elastic tape for the control of hand oedema in patients with a wrist fracture treated in a cast: a study protocol

The potential of inhibiting glutamine uptake as a therapeutic target for multiple myeloma

Assessment and pain management during the triage phase of children with extremity trauma. A retrospective analysis in a Pediatric Emergency Room after the introduction of the PIPER recommendations

Angiogenesis and Multiple Myeloma

The use of adhesive elastic tape for hand oedema control in patients with a wrist fracture treated in a cast: A pilot study

Relationship between Bone Marrow PD-1 and PD-L1 Expression and the Presence of Osteolytic Bone Disease in Multiple Myeloma Patients

CD14+CD16+ Monocyte Binding to Myeloma Cells Is Required for Daratumumab Dependent Killing in Multiple Myeloma Patients

Effect of Continuous Lenalidomide Treatment on Copy Number Alteration and Cytogenetic Abnormalities in Multiple Myeloma Cells

Suchergebnisse filtern